Down-regulation of MCT1 expression occurs as an early event in the adenoma–carcinoma sequence and, in carcinomas, is associated with reduced abundance of the low affinity glucose transporter GLUT2 and the expression of the high affinity glucose transporter, GLUT1. Here, SLC2A1 is linked to carcinoma.